Articles by Disease (Renal Cell Carcinoma)

Implications of FLT3 Mutations in the Therapy of Acute Myeloid Leukemia

Journal: Reviews on Recent Clinical Trials
Volume: 2
Page: 135-141
Author(s): Ryan J. Mattison, Kelly R. Ostler, Frederick L. Locke and Lucy A. Godley

Review of Clinic Trials: Agents Targeting c-Met

Journal: Reviews on Recent Clinical Trials
Volume: 2
Page: 143-147
Author(s): Oyewale Abidoye, Nadh Murukurthy and Ravi Salgia

Potential Utilization of Bystander / Abscopal-Mediated Signal Transduction Events in the Treatment of Solid Tumors

Journal: Current Signal Transduction Therapy
Volume: 2
Page: 129-143
Author(s): Matthew E. Peters, Mohammed M. Shareef, Seema Gupta, Marianna Zagurovskaya-Sultanov, Munira Kadhim, Mohammed Mohiuddin and Mansoor M. Ahmed

Carbonic Anhydrase Inhibitors and the Management of Cancer

Journal: Current Topics in Medicinal Chemistry
Volume: 7
Page: 865-878
Author(s): Silvia Pastorekova, Juraj Kopacek and Jaromir Pastorek

Dual Carbonic Anhydrase - Cyclooxygenase-2 Inhibitors

Journal: Current Topics in Medicinal Chemistry
Volume: 7
Page: 885-891
Author(s): Jean-Michel Dogne, Anne Thiry, Domenico Pratico, Bernard Masereel and Claudiu T. Supuran

Integrins: Novel Therapeutic Targets for Cardiovascular Diseases

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 5
Page: 109-132
Author(s): Hind Lal, Rakeshwar S. Guleria, Donald M. Foster, Guangrong Lu, Linley E. Watson, Sandhya Sanghi, Manuela Smith and David E. Dostal

Emerging Therapeutic Approaches Multi-Targeting Receptor Tyrosine Kinases and G Protein-Coupled Receptors in Cardiovascular Disease

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 5
Page: 133-145
Author(s): C. Flordellis, P. Papathanasopoulos, A. Lymperopoulos, J. Matsoukas and H. Paris